Drug information for TALACEN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 650MG;EQ 25MG BASE Discontinued   ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE Pentazocine SANOFI AVENTIS US 18458
2011-06-29 Label

2011-06-28 Letter

2011-03-08 Letter

2011-03-07 Label

2008-08-12 Letter

2003-07-28 Letter

Drug Adverse Effects information for TALACEN

Role code Indications Reaction # Reports
C ANTICOAGULANT THERAPY DEPRESSION 1
C ANTICOAGULANT THERAPY PULMONARY EMBOLISM 1
C HEADACHE DEPRESSION 1
C HEADACHE PULMONARY EMBOLISM 1
C MIGRAINE DEPRESSION 1
C MIGRAINE PULMONARY EMBOLISM 1
C OSTEOPOROSIS ACTINIC KERATOSIS 2
C OSTEOPOROSIS ANAEMIA OF CHRONIC DISEASE 2
C OSTEOPOROSIS ANGIOPATHY 2
C OSTEOPOROSIS ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST POSITIVE 2
C OSTEOPOROSIS ARTHROPATHY 2
C OSTEOPOROSIS ARTHROPOD BITE 2
C OSTEOPOROSIS BASAL CELL CARCINOMA 2
C OSTEOPOROSIS BONE LOSS 2
C OSTEOPOROSIS BRONCHITIS 2
C OSTEOPOROSIS BUNION 2
C OSTEOPOROSIS CARDIAC MURMUR 2
C OSTEOPOROSIS CARPAL TUNNEL SYNDROME 2
C OSTEOPOROSIS CELLULITIS 2
C OSTEOPOROSIS CONTUSION 2
C OSTEOPOROSIS CUTANEOUS LUPUS ERYTHEMATOSUS 2
C OSTEOPOROSIS DECUBITUS ULCER 2
C OSTEOPOROSIS DEHYDRATION 2
C OSTEOPOROSIS DENTAL FISTULA 2
C OSTEOPOROSIS DRY SKIN 2
C OSTEOPOROSIS EXCORIATION 2
C OSTEOPOROSIS EYE DISORDER 2
C OSTEOPOROSIS FAILURE TO THRIVE 2
C OSTEOPOROSIS FALL 2
C OSTEOPOROSIS FISTULA DISCHARGE 2
C OSTEOPOROSIS GINGIVAL BLEEDING 2
C OSTEOPOROSIS GINGIVAL DISORDER 2
C OSTEOPOROSIS GINGIVAL PAIN 2
C OSTEOPOROSIS GINGIVAL RECESSION 2
C OSTEOPOROSIS GINGIVITIS 2
C OSTEOPOROSIS GLAUCOMA 2
C OSTEOPOROSIS IMPAIRED HEALING 2
C OSTEOPOROSIS INCREASED TENDENCY TO BRUISE 2
C OSTEOPOROSIS INTERVERTEBRAL DISC DEGENERATION 2
C OSTEOPOROSIS LIP ULCERATION 2
C OSTEOPOROSIS LOOSE TOOTH 2
C OSTEOPOROSIS MELANOCYTIC NAEVUS 2
C OSTEOPOROSIS MITRAL VALVE PROLAPSE 2
C OSTEOPOROSIS MULTI-ORGAN FAILURE 2
C OSTEOPOROSIS MYELODYSPLASTIC SYNDROME 2
C OSTEOPOROSIS OEDEMA MOUTH 2
C OSTEOPOROSIS OEDEMA PERIPHERAL 2
C OSTEOPOROSIS ORAL DISORDER 2
C OSTEOPOROSIS ORAL INFECTION 2
C OSTEOPOROSIS OSTEOMYELITIS 2
C OSTEOPOROSIS OSTEONECROSIS OF JAW 2
C OSTEOPOROSIS PATHOLOGICAL FRACTURE 2
C OSTEOPOROSIS PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2
C OSTEOPOROSIS PERIPHERAL VASCULAR DISORDER 2
C OSTEOPOROSIS PHOTODERMATOSIS 2
C OSTEOPOROSIS PNEUMONIA 2
C OSTEOPOROSIS POOR PERSONAL HYGIENE 2
C OSTEOPOROSIS PSORIASIS 2
C OSTEOPOROSIS RASH 2
C OSTEOPOROSIS RENAL FAILURE ACUTE 2
C OSTEOPOROSIS RENAL FAILURE CHRONIC 2
C OSTEOPOROSIS SEBORRHOEIC KERATOSIS 2
C OSTEOPOROSIS SKIN ULCER 2
C OSTEOPOROSIS SQUAMOUS CELL CARCINOMA OF SKIN 2
C OSTEOPOROSIS TOOTH DISORDER 2
C OSTEOPOROSIS TREATMENT NONCOMPLIANCE 2
C OSTEOPOROSIS WEIGHT DECREASED 2
C PREMENSTRUAL SYNDROME DEPRESSION 2
C PREMENSTRUAL SYNDROME PULMONARY EMBOLISM 2
C SCHIZOAFFECTIVE DISORDER AGGRESSION 2
C SCHIZOAFFECTIVE DISORDER HOSPITALISATION 1
Ads by Google